Organization | Fundación Vía Libre

Fundación Vía Libre Report issue

Foundation Phase 4

Founded: Córdoba Argentina (2000)

Organization Overview

First Clinical Trial

2009

NCT00925288

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

NGO Via Libre

Active Ingredients

Drugs in Phase 4 Trials (6)

cobicistat (stribild) (1 trial)

efavirenz (sustiva) (1 trial)

elvitegravir (vitekta) (1 trial)

emtricitabine (emtriva) (1 trial)

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)

tenofovir (viread) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

HIV Infections (Phase 4)

Infections (Phase 4)

Papillomavirus Infections (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 2
# of Trial APIs: 6